Investors

2024 Second quarter announcement

We announced our second quarter 2024 results on Wednesday 31 July. Access our second quarter results and latest Annual Report below.

We’re confident in our future

With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide.

Speeches and presentations

Endometrial Cancer Science Image

Getting ahead of Oncology with GSK management

Watch the recording
17 June 2024

GSK management held a virtual event on 17 June at 8:00 AM EST / 1:00 PM GMT. The event featured a presentation and an interactive Q&A session. A replay is available on demand.

GSK Tech Human Image

ESG Investor Education Event (ESG Performance Report)

Watch the webcast
19 March 2024

GSK’s VP of Reputation and Responsible Business, Clare Griffin, and VP of Sustainability, Claire Lund, presented a 45 minute virtual event focused on the newest set of ESG data for the company – the 2023 ESG Performance Report.

ESG Investor Education Event presentation (PDF - 325KB)

Emma Walmsley

42nd annual JP Morgan Healthcare Conference

Listen to the webcast
09 January 2024

Emma Walmsley, Chief Executive Officer, participated in the 42nd annual JP Morgan Healthcare Conference on Tuesday 9 January at 07:30-08:10am PST / 15:30-16:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion.

JP Morgan Healthcare Conference presentation (PDF - 1,066kb)

Lungs science image

Getting ahead of Respiratory Diseases with GSK management

Watch the recording
30 November 2023

GSK management held a virtual event on 30 November at 8:00 AM EST / 1:00 PM GMT. The event featured a presentation and an interactive Q&A session. A replay is available on demand.

GSK share price

Share price tool

Detailed information on GSK's share price, including an interactive chart

Go to share price tool
two scientists talking

Get in touch with our investor team